** CStone Pharmaceuticals 2616.HK slides 13% to HK$3, lowest since February 25
** Stock set for biggest one-day pct decline since March 7, 2024; top pct loser on Hong Kong bourse
** Chinese biopharma developer plans to sell 80 mln new shares to third party investors to raise HK$234.6 mln ($30.2 mln) for R&D and general corporate purposes
** Says shares will be issued at HK$2.933, representing ~15% discount to Tuesday's close of HK$3.45
** Stock gains 30.4% YTD
($1 = HK$7.7808)
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。
如果下载按钮点击无跳转，请点击右上角菜单选择 “在浏览器打开”